TNF and cancer: Thus, we conducted a systematic review and meta-analysis of head-to-head comparative effectiveness studies of JAK inhibitors vs TNF antagonists for serious infections, malignant neoplasms, MACEs, and VTE to provide a comprehensive safety assessment across IMIDs.